Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cefuroxime 250mg tablets
0501021K0AAABAB
|
Cefuroxime axetil | Cefuroxime axetil | Infections | 676 |
|
Cefuroxime 125mg/5ml oral suspension
0501021K0AAACAC
|
Cefuroxime axetil | Cefuroxime axetil | Infections | 61 |
|
Cefuroxime 125mg tablets
0501021K0AAAAAA
|
Cefuroxime axetil | Cefuroxime axetil | Infections | 49 |
|
Cefuroxime 125mg granules for oral suspension sachets
0501021K0AAADAD
|
Cefuroxime axetil | Cefuroxime axetil | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.